08156 SINOPHARM TECH
- 0.096
- -0.019-16.52%
SINOPHARM TECH News
Sinopharm Technology Co., Ltd. (08156.HK): Withdrawal of winding-up petition
Sinopharm Technology Co., Ltd. (08156.HK) issued a notice. The petitioner and the company have signed and submitted a consent summons to the High Court to withdraw the petition. At a hearing on May 8, 2024, the High Court announced an order to withdraw the petition.
Sinopharm Technology Co., Ltd. (08156.HK): Petition to wind up the company was withdrawn
Gelonghui, May 8, 丨 Sinopharm Technology Co., Ltd. (08156.HK) announced that the petitioner filed a petition against the company. The petitioner and company have signed and filed a consent summons with the High Court to revoke the petition. At a hearing on May 8, 2024, the High Court announced an order to withdraw the petition.
Sinopharm Technology Co., Ltd. (08156): Withdrawal of winding-up petition
Sinopharm Technology Co., Ltd. (08156) issued a notice. The petitioner and the company have signed and submitted a subpoena of consent to the High Court to...
SINOPHARM TECH: INTERIM REPORT 2023/2024
Sinopharm Technology Co., Ltd. (08156) announced interim results. Shareholders' losses of HK$2,876 million were converted from profit to loss year-on-year
Sinopharm Technology Co., Ltd. (08156) announced interim results for the six months ended December 31, 2023. The group took...
SINOPHARM TECH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2023
Sinopharm Technology Co., Ltd. (08156): The hearing of the winding-up petition will be adjourned until April 3
Sinopharm Technology Co., Ltd. (08156) issued an announcement. At a hearing held on February 7, 2024, the High Court ordered...
Sinopharm Technology Co., Ltd. (08156.HK) obtained Chen Jianhao's OTC shareholding of 27.09.76 million shares, worth approximately HK$1,346,700
On January 23, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 23, Chen Jianhao increased his OTC share holdings of $Sinopharm Technology (08156.HK) shares by $27.09.76 million at an average price of HK$0.0497 per share on January 18, worth about HK$1,346,700. After increasing his holdings, Chen Jianhao's latest shareholding was 27.0976 million shares, and the good position ratio increased from 0.00% to 14.75%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) must disclose their
Lin Ruiqiang sold 27.09.76 million common shares of Sinopharm Technology Co., Ltd. (08156.HK) off the market, worth approximately HK$1,346,700
On January 23, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 23, Lin Ruiqiang sold $27.097 million common shares of $Sinopharm Technology (08156.HK) shares off the market at an average price of HK$0.0497 per share on January 18, worth about HK$1.346,700. After the sale, Lin Ruiqiang's latest shareholding was 0 shares, and the good position ratio dropped from 14.75% to 0.00%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share rights in listed companies
China IoT: China's warehousing index in November was 52.2%, down 1.3 percentage points from the previous month
On December 4, China's warehousing index, jointly surveyed by the China Federation of Logistics and Purchasing and China Storage Development Co., Ltd., was 52.2% in November 2023, up 1.3 percentage points from the previous month.
SINOPHARM TECH: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 30 JUNE 2023
Sinopharm Technology Co., Ltd. (08156.HK): Postponement of winding-up petition hearing
Gelonghui November 15 | Sinopharm Technology Co., Ltd. (08156.HK) announced that the petitioner filed a petition against the company. At the hearing held on November 15, 2023, the High Court ordered the hearing of the petition to be adjourned until February 7, 2024.
SINOPHARM TECH: FIRST QUARTERLY REPORT 2023/2024
SINOPHARM TECH: FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 30 SEPTEMBER 2023
SINOPHARM TECH: DATE OF BOARD MEETING
Sinopharm Technology Co., Ltd. (08156) announced annual results, losses attributable to equity holders of HK$106.35 million narrowed by 87.91% year-on-year
Sinopharm Technology Co., Ltd. (08156) announced its results for the year ended June 30, 2023, with revenue of 4283.9...
SINOPHARM TECH: ANNUAL REPORT 2023
SINOPHARM TECH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2023
Sinopharm Technology Co., Ltd. (08156) expects annual shareholders' losses to be reduced by 80% to 90%
Sinopharm Technology Co., Ltd. (08156) announced that for the year ended June 30, 2023, the Group is expected to obtain public access...
SINOPHARM TECH: INSIDE INFORMATION - EXPECTED SIGNIFICANT DECREASE IN LOSS
Analysis
Price Target
No Data
